WEDNESDAY, SEPTEMBER 30
9:00 am - 9:30 am
Spotlight Talk: Using AI to Accelerate Drug Discovery for SARS-CoV-2 and the Ongoing COVID-19 Global Pandemic
Alex Zhavoronkov -
CEO,
Insilico Medicine
9:45 am - 10:15 am
The Evolution of Talent & Teams: Training Up for the Convergence of Science and Tech
Chris Garabedian -
CEO, Portfolio Manager,
Xontogeny, PXV Fund
Rafael Rosengarten - Chief Executive Officer, Genialis
Elizabeth Roberts - Chief People Officer, eGenesis, Inc.
Elaine Hamm Ph.D - CEO, Ascend BioVentures
A closer look at the current evolution of talent at the crossroads of scientific knowledge and tech know-how. Examine the evolution of the workforce for tech-enabled drug development and next gen therapies. What strategic planning must be undertaken by hiring leaders, CEO's and other decision makers when building out your team and company culture?
10:15 am - 10:45 am
Breakout Networking & Informal Discussion: Early Stage Development, Capital & Financing
Chris Garabedian -
CEO, Portfolio Manager,
Xontogeny, PXV Fund
Marc Appel - CEO, Orange Grove Bio
Ashley Zehnder - Founder, CEO, Fauna Bio
Moderated, Informal Networking Discussion on Perspectives on Early Stage Financing, Venture Capital & Investments in AI, Automation & Data Based Biotech
10:45 am - 11:15 am
Discussion Panel: From East to West: Deploying Engine onto Biological Problems
Laurent Audoly -
Founder & CEO,
Parthenon
James Zanewicz - Chief Business Officer, Tulane University
Amanda Way - Investor, Healthcare, Emerson Collective
Take part in a discussion that brings together perspectives from biotech hubs around the US to gain insight into varying computational approaches in drug discovery and the varying biotech development landscape around the nation. What is the opportunity that exists from converging trajectories to increase the probability of success in developing transformative treatments?
11:30 am - 12:00 pm
How Data Science is Leading R&D for Pharma
Maria Luisa Pineda -
Founder & CEO,
Envisagenics
Katherine Bettencourt - Senior Scientist, Janssen Pharmaceuticals
12:15 pm - 12:45 pm
Spotlight Talk: Bias, Fairness and Explainability: Required for Advancement of AI in Healthcare
Brandon Allgood -
SVP, Data Science & AI,
Integral Health
How might industry address the issues of Fairness, Privacy and Anonymity, Explainability and Interpretability that affect the use of AI and ML in medicine, and the wider societal issues surrounding ethics and legislation? Determine the most relevant aspects to consider to support the medical application and acceptance of AI- and ML-based technologies in healthcare
